PMID- 29511381
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240313
IS  - 1741-427X (Print)
IS  - 1741-4288 (Electronic)
IS  - 1741-427X (Linking)
VI  - 2017
DP  - 2017
TI  - Could We Really Use Aloe vera Food Supplements to Treat Diabetes? Quality Control 
      Issues.
PG  - 4856412
LID - 10.1155/2017/4856412 [doi]
LID - 4856412
AB  - Diabetes UK has recently listed a number of herbs and spices that have been 
      clinically shown to improve blood glucose control in type-2 diabetes patients and 
      the diabetes high-risk group. With Aloe vera being top in this list, its health 
      benefit along with health and beauty/food retailers supplying it was illustrated 
      in detail. Previous article from this laboratory scrutinised the merit of using 
      A. vera as an alternative therapy to prescription antidiabetic drugs and the risk 
      of using food supplements in the market which do not qualify as drug 
      preparations. In continuation of this discussion, the present study assesses 
      three Aloe Pura brands and one Holland and Barret brand of A. vera juice 
      supplements in the UK market through chromatographic and spectroscopic analysis. 
      While the polysaccharide active ingredient, acemannan, appears to be within the 
      recommended limit, it was found that Aloe Pura (one of the best-selling brands 
      for A. vera supplement) products have benzoate additive that does not appear in 
      the supplement levels. Moreover, two of the Aloe Pura brand juices contain 
      methanol, suggesting that the International Aloe Science Council (IASC) 
      certification does not guarantee the medicinal quality of these products. The 
      therapeutic fitness of such supplements is discussed.
FAU - Habtemariam, Solomon
AU  - Habtemariam S
AUID- ORCID: 0000-0001-6743-2244
AD  - Pharmacognosy Research Laboratories & Herbal Analysis Services UK, University of 
      Greenwich, Medway Campus, Chatham Maritime, Kent ME4 4TB, UK.
LA  - eng
PT  - Journal Article
DEP - 20171206
PL  - United States
TA  - Evid Based Complement Alternat Med
JT  - Evidence-based complementary and alternative medicine : eCAM
JID - 101215021
PMC - PMC5736930
EDAT- 2017/01/01 00:00
MHDA- 2017/01/01 00:01
PMCR- 2017/12/06
CRDT- 2018/03/08 06:00
PHST- 2017/09/08 00:00 [received]
PHST- 2017/11/05 00:00 [accepted]
PHST- 2018/03/08 06:00 [entrez]
PHST- 2017/01/01 00:00 [pubmed]
PHST- 2017/01/01 00:01 [medline]
PHST- 2017/12/06 00:00 [pmc-release]
AID - 10.1155/2017/4856412 [doi]
PST - ppublish
SO  - Evid Based Complement Alternat Med. 2017;2017:4856412. doi: 10.1155/2017/4856412. 
      Epub 2017 Dec 6.